Cargando…
A Novel Gene Signature Based on CDC20 and FCN3 for Prediction of Prognosis and Immune Features in Patients with Hepatocellular Carcinoma
Long-term survivals of patients with hepatocellular carcinoma (HCC) remain unfavorable, which is largely attributed to active carcinogenesis. Growing studies have suggested that the reliable gene signature could act as an independent prognosis factor for HCC patients. We tried to screen the survival...
Autores principales: | Lai, Xing, Wu, Ya-kun, Hong, Guo-qing, Li, Jun-ke, Luo, Qing, Yuan, Jin, Dai, Guo-hua, Liu, Shuang-quan, Feng, Hua-guo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986430/ https://www.ncbi.nlm.nih.gov/pubmed/35402624 http://dx.doi.org/10.1155/2022/9117205 |
Ejemplares similares
-
Effect of Polymorphisms in the FCN1, FCN2, and FCN3 Genes on the Susceptibility to Develop Rheumatoid Arthritis: A Systematic Review
por: Gil-Quiñones, Sebastián R., et al.
Publicado: (2022) -
Frequency and distribution of FCN2 and FCN3 functional variants among MBL2 genotypes
por: Bjarnadottir, Helga, et al.
Publicado: (2016) -
Connection Between CDC20 Expression and Hepatocellular Carcinoma Prognosis
por: Zhang, Xianfeng, et al.
Publicado: (2021) -
FCN3 inhibits the progression of hepatocellular carcinoma by suppressing SBDS-mediated blockade of the p53 pathway
por: Ma, Dong, et al.
Publicado: (2023) -
Time Series Classification with InceptionFCN
por: Usmankhujaev, Saidrasul, et al.
Publicado: (2021)